Sanai Health Group: Sale of Subsidiary Company Equity

San Ai Health Group Announcement: On November 10, 2025, the company entered into an agreement with the buyer to sell the subsidiary company's equity for a price of approximately 18.69 million yuan, to be settled in cash. The sale constitutes a disclosure transaction for the company, but is exempt from the requirement of shareholder approval. The maximum applicable percentage of the sale transaction is over 5% but less than 25%. After the transaction is completed, the company will no longer hold any equity in the target company, and the target company will no longer be a subsidiary of the company.